Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

VISTA.Today
vista.today > 2026 > 09 > annovis-bio-alzheimers-funding

Malvern Biotech Races to Raise $15M Before Make-or-Break Alzheimer's Data

5+ day, 16+ hour ago   (504+ words) A Malvern biotech is looking to raise an additional $15 million by the end of the year as it advances a closely watched experimental treatment for Alzheimer’s disease. Annovis Bio, an eight-person company on Lindenwood Drive, is running a late-stage Alzheimer’s…...

semafor.com
semafor.com > article > 08 > 20 > 2026 > tempus-ais-biotech-deal-attracts-investor-attention

Tempus AI’s biotech deal attracts investor attention

3+ week, 2+ day ago   (208+ words) The deal would have passed by without much notice, but Personalis’ technology is crucial to building the revolutionary personalized cancer therapies announced earlier this week by Merck and Moderna. Tempus AI’s biotech deal attracts investor attention A tiny biotech deal…...